Joseph Mansour, Presenter: Nothing to Disclose

Christine O. Menias MD, Abstract Co-Author: Nothing to Disclose

Julie Tanios el-Ferzli MD, Abstract Co-Author: Nothing to Disclose

Wissam Mansour, Abstract Co-Author: Nothing to Disclose

Raghid Nabih Kikano MD, Abstract Co-Author: Nothing to Disclose

Sanjeev Bhalla MD, Abstract Co-Author: Nothing to Disclose

1. Review epidemiology, clinical presentation, and pathological features of PMP 2. Review tumor behavior including the pathophysiology of disease spread and treatment options. 3. To review the cross sectional imaging findings in PMP  

1. Epidemiology, clinical presentation, and tumor pathological features of PMP. 2. Tumor behavior, pathophysiology of disease spread and treatment options a. Distribution related to peritoneal fluid absorption and gravity b. Treatment of PMP and PMP-type conditions 3. Cross-sectional imaging findings of PMP with examples. a. CT scan features of PMP b. Role of MRI c. Differentiation of PMP from disseminated mucinous carcinomatosis by imaging 4. Conclusion SUMMARY Pseudomyxoma peritonei (PMP) is a rare condition characterized by a productive mucinous ascites, filling the peritoneal cavity. PMP is a histologically benign peritoneal tumor and is not to be confused with disseminated mucinous carcinomatosis. PMP can originate from many organs, ruptured appendiceal mucinous adenoma and low grade ovarian neoplasms being the most common. Cross sectional imaging is crucial in assessing this condition and operability. The purpose of this exhibit is to illustrate the key imaging features, how they help differentiate PMP from peritoneal carcinomatosis and determine choice of treatment.  

http://abstract.rsna.org/uploads/2014/14004512/14004512_3d78.pdf

Mansour, J, Menias, C, el-Ferzli, J, Mansour, W, Kikano, R, Bhalla, S, Jelly Belly: Imaging of Pseudomyxoma Peritonei (PMP).  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14004512.html